Vernon Tam

Vernon Tam is an accomplished finance professional with extensive experience in the investment banking sector, currently serving as Vice President and Team Head of IPO Vetting for Biotech at Hong Kong Exchanges and Clearing Limited (HKEX) since 2021. Tamar has a comprehensive background in corporate finance, having worked as Vice President at Deutsche Bank from 2014 to 2021, handling IPOs, M&A, and structured lending within the healthcare sector, as well as covering the Hong Kong and Greater China regions. Prior experience includes roles as an Associate at BOCI and a Sales Associate at Merck, where Tam specialized in pharmaceutical products. An academic background includes an MBA in Healthcare Finance from Duke University, an MBA in Finance from CUHK Business School, an M.Phil in Obstetrics and Gynaecology from HKUMed, and a BSc in Molecular Biology from The University of Hong Kong.